Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cytokine-Targeted Therapy in Severely Ill Covid-19 Patients: Options and Cautions Publisher



Rahmati M1 ; Moosavi MA2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cancer Biology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Molecular Medicine, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran

Source: Eurasian Journal of Medicine and Oncology Published:2020


Abstract

[No abstract available]
Other Related Docs
10. The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran, International Journal of Hematology-Oncology and Stem Cell Research (2023)
14. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
18. Jak Inhibition As a New Treatment Strategy for Patients With Covid-19, International Archives of Allergy and Immunology (2020)
20. Covid-19 in Patients With Cancer: Risks and Precautions, American Journal of Emergency Medicine (2021)
22. A Review of Antibiotic Efficacy in Covid-19 Control, Journal of Immunology Research (2023)
25. The Controversial Effect of Smoking and Nicotine in Sars-Cov-2 Infection, Allergy# Asthma and Clinical Immunology (2023)
32. Melatonin Could Be Beneficial in Sars-Cov-2 Therapy, Natural Products Journal (2021)
34. Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19, Allergy# Asthma and Clinical Immunology (2021)
35. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
40. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)
43. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
44. Covid-19’S Immuno-Pathology and Cardiovascular Diseases, Journal of Investigative Medicine (2023)
46. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)